Evolution of the Average Target: Plains GP Holdings, L.P.

Evolution of the Average Target - Plains GP Holdings, L.P.

Evolution of the Target Price: Plains GP Holdings, L.P.

Evolution of the Target Price - Plains GP Holdings, L.P.

Changes in Analyst Recommendations: Plains GP Holdings, L.P.

2b73a31bd3418a.jQG71FU8YliZe7gExAr_ji2qLXVUZbDU9JE29ZZYvR8.9FGLrAxbNCztKtxGjV-K5x7lXRdhLPmehuVZnf4e6GjfNI7iAH0TKqwugA~e6dbd18d6e0ede5051b93d4fab6a78ab
10-09 UBS Adjusts Price Target on Plains GP Holdings to $30 From $26, Maintains Buy Rating MT
06-04 Goldman Sachs Upgrades Plains GP to Neutral From Sell, Adjusts Price Target to $24 From $18 MT
25-02-11 Truist Raises Price Target on Plains GP Holdings to $24 From $23, Keeps Buy Rating MT
25-01-17 UBS Adjusts Price Target on Plains GP to $26 From $23, Keeps Buy Rating MT
25-01-10 Wolfe Upgrades Plains GP Holdings to Outperform From Peer Perform, Price Target is $22 MT
24-12-18 Wells Fargo Downgrades Plains GP to Equalweight From Overweight, Adjusts Price Target to $20 From $22 MT
24-10-25 Morgan Stanley Downgrades Plains GP to Equalweight, Price Target is $19 MT
24-07-02 UBS Adjusts Price Target on Plains GP to $23 From $22, Maintains Buy Rating MT
24-06-10 Morgan Stanley Raises Price Target on Plains GP Holdings to $20 From $19, Maintains Overweight Rating MT
24-05-13 UBS Adjusts Plains GP Holdings Price Target to $22 From $23, Maintains Buy Rating MT
24-05-08 Wells Fargo Raises Plains GP Holdings' Price Target to $20 From $19, Keeps Overweight Rating MT
24-04-16 Stifel Adjusts Price Target on Plains GP Holdings to $22 From $18, Maintains Buy Rating MT
24-04-12 Barclays Raises Plains GP Holdings' Price Target to $18 From $16, Keeps Underweight Rating MT
24-04-12 Goldman Sachs Adjusts Price Target on Plains GP to $16 From $14.50, Keeps Sell Rating MT
24-04-12 UBS Adjusts Plains GP Holdings Price Target to $23 From $22, Maintains Buy Rating MT
23-11-06 Truist Securities Raises Price Target on Plains GP to $21 From $17, Maintains Buy Rating MT
23-10-06 Goldman Sachs Reinstates Plains GP Holdings at Sell With $13.50 Price Target MT
23-09-25 Barclays Downgrades Plains GP to Underweight From Equalweight, Price Target is $15 MT
23-09-06 Citigroup Downgrades Plains GP Holdings to Neutral From Buy, Adjusts Price Target to $15.50 From $14 MT
23-07-21 Raymond James Adjusts Price Target on Plains GP Holdings to $18 From $17, Maintains Strong Buy Rating MT
23-07-20 Morgan Stanley Adjusts Price Target on Plains GP to $18 From $17, Maintains Overweight Rating MT
23-07-12 Mizuho Adjusts Price Target on Plains GP to $19 From $17, Maintains Buy Rating MT
23-07-11 UBS Adjusts Price Target on Plains GP Holdings to $23 From $22, Maintains Buy Rating MT
23-06-05 UBS Adjusts Plains GP Price Target to $22 From $21, Maintains Buy Rating MT
23-04-25 Morgan Stanley Adjusts Price Target on Plains GP Holdings to $17 From $16, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.77%
+18.51%
+29.16%
+15.23%
+20.62%
+12.99%
+28.8%
+16.84%
+15.38%
+10.3%
Average +17.16%
Weighted average by Cap. +18.89%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.53USD
Average target price
26.85USD
Spread / Average Target
+5.16%
High Price Target
30.00USD
Spread / Highest target
+17.51%
Low Price Target
20.00USD
Spread / Lowest Target
-21.66%

Analyst Consensus Detail

Analyst consensus - Plains GP Holdings, L.P.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Plains GP Holdings, L.P.
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Plains GP Holdings, L.P.
  1. Stock Market
  2. Stocks
  3. PAGP Stock
  4. Consensus Plains GP Holdings, L.P.